Skip to main content
HIGH TECH PHARM CO.,LTD. logo

HIGH TECH PHARM CO.,LTD. — Investor Relations & Filings

Ticker · 106190 ISIN · KR7106190002 KO Manufacturing
Open in API
Filings indexed 169 across all filing types
Latest filing 2019-11-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 106190

About HIGH TECH PHARM CO.,LTD.

http://www.htpharm.com/eng/

HIGH TECH PHARM CO.,LTD. is a pharmaceutical company specializing in the development and manufacturing of active pharmaceutical ingredients (APIs), with a primary focus on sterile, carbapenem-based antibiotic raw materials. Established in 1998, the company has gained global recognition for its advanced technology and high-quality products, which are supplied to over 40 countries. A significant majority of its sales are generated from exports to demanding overseas markets, including Europe. The company operates state-of-the-art manufacturing facilities, such as its Chungju plant, designed to meet the rigorous standards of advanced regulatory authorities like the U.S. FDA and European EDQM. Through a commitment to a quality-first policy and continuous research and development, HIGH TECH PHARM aims to solidify its position as a leading global supplier of antibiotic drug substances.

Recent filings

Filing Released Lang Actions
분기보고서 (2019.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 하이텍팜' covering the period from 2019-01-01 to 2019-09-30. It contains detailed financial information, business operations, management discussions, and capital structure data, which is characteristic of a comprehensive interim/quarterly financial report. It is not an announcement or a certification, but the report itself. 9M 2019
2019-11-14 Korean
[기재정정]분기보고서 (2019.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) from a Korean company, HiTechPharm. It explicitly states it is a '정정신고' (Correction Report) for a previously filed quarterly report (2019.03). It contains detailed financial statements including the Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, and Statement of Cash Flows for the specified period. Since it provides substantive financial data and is a comprehensive report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2019
2019-08-14 Korean
반기보고서 (2019.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '주식회사 하이텍팜' (High Tech Pharm Co., Ltd.) covering the period from January 1, 2019, to June 30, 2019. It contains detailed financial information, business operations, management discussions, and governance details, which are characteristic of an interim/quarterly report. It is not a mere announcement or certification, as it provides substantive financial data and analysis. H1 2019
2019-08-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the share ownership and specific transaction changes (buy/sell) by an executive (Woo Jong-O) of the company Hitech Pharm. This type of filing is classified as 'Director's Dealing' (DIRS) as it reports insider transactions and changes in ownership status by company management.
2019-08-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea (DART system) to report insider trading or changes in shareholdings by company directors and executives. Based on the provided definitions, this corresponds to 'Director's Dealing' (DIRS).
2019-08-01 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'High Tech Pharm' (주식회사 하이텍팜) covering the period from January 1, 2019, to March 31, 2019. It contains detailed financial data, business operations, management discussions, and capital structure information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.